Clinical, morphologic, and cytogenetic features were exam-ined in a group of 68 children with myelodysplasia (MDS) referred t o a single institution between 1971-1991. The mor-phologic French-American-British (FA61 system of classifi-cation proved of limited value in this group of patients be-cause 50 % of the cases were categorized as chronic myelomonocytic leukemia and three patients with eosino-philia and MDS were unclassifiable. Cytogenetic analysis was performed in 63 cases and clonal abnormalities were detected in 5596; the most common chromosome involved was number 7. Modification of the FAB system to incorpo-rate additional diagnostic features such as pretreatment fe-tal hemoglobin (Hb F) and cytogenetics allowed incorpora-tion of ...
Myelodysplastic syndromes (MDS) are rare in children, representing 3% or less of all hematopoietic m...
Fourteen pediatric cases of myelodysplastic syndrome according to French-American-British Cooperativ...
We analyzed cytogenetically 105 patients with hypocellular primary MDS and their clinical implicatio...
Clinical, morphologic, and cytogenetic features were exam-ined in a group of 68 children with myelod...
Forty-four cases of myelodysplasia in children were studied. A third of the cases were unclassifiabl...
Three consecutive cases of pediatric myelodysplastic syndrome (MDS) diagnosed over a three-year peri...
Myelodysplastic syndromes (MDS) are clonal disorders of the multipotent hematopoietic stem cell char...
Chronic myelomonocytic leukemia (CMML) is a rare hematopoietic malignancy of childhood. To define th...
Myelodysplastic syndromes (MDS) are clonal disorders of the multipotent hematopoietic stem cell char...
Chronic myelomonocytic leukemia (CMML) is a rare hematopoietic malignancy of childhood. To define th...
We reviewed the clinical features, treatment, and outcome of 100 children with myelodysplastic syndr...
Chronic myelomonocytic leukemia (CMML) is a rare hematopoietic malignancy of childhood. To define th...
Myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML) are rare hematopoietic s...
Myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML) are rare hematopoie...
Myelodysplastic syndrome (MDS) constitutes 1-16% percent of haematological malignancies in childhood...
Myelodysplastic syndromes (MDS) are rare in children, representing 3% or less of all hematopoietic m...
Fourteen pediatric cases of myelodysplastic syndrome according to French-American-British Cooperativ...
We analyzed cytogenetically 105 patients with hypocellular primary MDS and their clinical implicatio...
Clinical, morphologic, and cytogenetic features were exam-ined in a group of 68 children with myelod...
Forty-four cases of myelodysplasia in children were studied. A third of the cases were unclassifiabl...
Three consecutive cases of pediatric myelodysplastic syndrome (MDS) diagnosed over a three-year peri...
Myelodysplastic syndromes (MDS) are clonal disorders of the multipotent hematopoietic stem cell char...
Chronic myelomonocytic leukemia (CMML) is a rare hematopoietic malignancy of childhood. To define th...
Myelodysplastic syndromes (MDS) are clonal disorders of the multipotent hematopoietic stem cell char...
Chronic myelomonocytic leukemia (CMML) is a rare hematopoietic malignancy of childhood. To define th...
We reviewed the clinical features, treatment, and outcome of 100 children with myelodysplastic syndr...
Chronic myelomonocytic leukemia (CMML) is a rare hematopoietic malignancy of childhood. To define th...
Myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML) are rare hematopoietic s...
Myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML) are rare hematopoie...
Myelodysplastic syndrome (MDS) constitutes 1-16% percent of haematological malignancies in childhood...
Myelodysplastic syndromes (MDS) are rare in children, representing 3% or less of all hematopoietic m...
Fourteen pediatric cases of myelodysplastic syndrome according to French-American-British Cooperativ...
We analyzed cytogenetically 105 patients with hypocellular primary MDS and their clinical implicatio...